PROPEL BIO MANAGEMENT, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | MIST | 4.12M | $8.32M |
 | ACHV | 3.79M | $18.82M |
 | PAGP | 1.27M | $24.35M |
 | IVA | 1.00M | $4.65M |
 | CMPS | 862K | $5.95M |
 | PHAT | 741K | $12.29M |
 | KYTX | 667K | $6.27M |
 | SABS | 653K | $2.44M |
 | DCTH | 439K | $4.43M |
 | VRDN | 283K | $8.79M |
 | CLDX | 154K | $4.19M |
 | ATHA | 149K | $1.13M |
 | RGNX | 117K | $1.68M |
 | NKTR | 83K | $3.50M |
 | ZVRA | 64K | $570.60K |
 | LENZ | 59K | $945.36K |
 | AARD | 46K | $609.11K |
 | KLRS | 42K | $354.93K |
Milestone Pharmaceuticals Inc.
MIST
Shares Held
4.12M
Value
$8.32M
Achieve Life Sciences, Inc.
ACHV
Shares Held
3.79M
Value
$18.82M
Plains GP Holdings, L.P.
PAGP
Shares Held
1.27M
Value
$24.35M
Inventiva S.A.
IVA
Shares Held
1.00M
Value
$4.65M
COMPASS Pathways plc
CMPS
Shares Held
862K
Value
$5.95M
Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
741K
Value
$12.29M
Kyverna Therapeutics, Inc.
KYTX
Shares Held
667K
Value
$6.27M
SAB Biotherapeutics, Inc.
SABS
Shares Held
653K
Value
$2.44M
Delcath Systems, Inc.
DCTH
Shares Held
439K
Value
$4.43M
Viridian Therapeutics, Inc.
VRDN
Shares Held
283K
Value
$8.79M
Celldex Therapeutics, Inc.
CLDX
Shares Held
154K
Value
$4.19M
Athira Pharma, Inc.
ATHA
Shares Held
149K
Value
$1.13M
REGENXBIO Inc.
RGNX
Shares Held
117K
Value
$1.68M
Nektar Therapeutics
NKTR
Shares Held
83K
Value
$3.50M
Zevra Therapeutics, Inc.
ZVRA
Shares Held
64K
Value
$570.60K
LENZ Therapeutics, Inc.
LENZ
Shares Held
59K
Value
$945.36K
Aardvark Therapeutics, Inc. Common Stock
AARD
Shares Held
46K
Value
$609.11K
Kalaris Therapeutics Inc
KLRS
Shares Held
42K
Value
$354.93K